129 related articles for article (PubMed ID: 8689245)
1. Design, synthesis and in vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agents.
Rose IC; Sharpe BA; Lee RC; Griffin JH; Capobianco JO; Zakula D; Goldman RC
Bioorg Med Chem; 1996 Jan; 4(1):97-103. PubMed ID: 8689245
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.
Goldman RC; Zakula D; Capobianco JO; Sharpe BA; Griffin JH
Antimicrob Agents Chemother; 1996 Apr; 40(4):1044-7. PubMed ID: 8849227
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of 2,3-oxidosqualene lanosterol-cyclase as potential antifungal agents.
Jolidon S; Polak AM; Guerry P; Hartman PG
Biochem Soc Trans; 1990 Feb; 18(1):47-8. PubMed ID: 2185085
[No Abstract] [Full Text] [Related]
4. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors.
Buckner FS; Griffin JH; Wilson AJ; Van Voorhis WC
Antimicrob Agents Chemother; 2001 Apr; 45(4):1210-5. PubMed ID: 11257036
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes.
Ng CK; Singhal V; Widmer F; Wright LC; Sorrell TC; Jolliffe KA
Bioorg Med Chem; 2007 May; 15(10):3422-9. PubMed ID: 17383187
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of a Series of Bis(pentylpyridinium) Compounds as Antifungal Agents.
Obando D; Koda Y; Pantarat N; Lev S; Zuo X; Bijosono Oei J; Widmer F; Djordjevic JT; Sorrell TC; Jolliffe KA
ChemMedChem; 2018 Jul; 13(14):1421-1436. PubMed ID: 29781143
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase.
Rabelo VW; Viegas DJ; Tucci EMN; Romeiro NC; Abreu PA
J Steroid Biochem Mol Biol; 2019 Jan; 185():189-199. PubMed ID: 30193921
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, specificity, and antifungal activity of inhibitors of the Candida albicans delta 24-sterol methyltransferase.
Ator MA; Schmidt SJ; Adams JL; Dolle RE; Kruse LI; Frey CL; Barone JM
J Med Chem; 1992 Jan; 35(1):100-6. PubMed ID: 1732516
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of a Candida albicans GGTase I inhibitor-alanine conjugate. Inhibition of Rho1p prenylation in C. albicans.
Murthi KK; Smith SE; Kluge AF; Bergnes G; Bureau P; Berlin V
Bioorg Med Chem Lett; 2003 Jun; 13(11):1935-7. PubMed ID: 12749902
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase.
Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R
Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of styrylpyridinium compounds against Candida albicans.
Vaitkienė S; Kuliešienė N; Sakalauskaitė S; Bekere L; Krasnova L; Vigante B; Duburs G; Daugelavičius R
Chem Biol Drug Des; 2021 Feb; 97(2):253-265. PubMed ID: 32772494
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antifungal, haemolytic and cytotoxic activities of a series of bis(alkylpyridinium)alkanes.
Obando D; Pantarat N; Handke R; Koda Y; Widmer F; Djordjevic JT; Ellis DH; Sorrell TC; Jolliffe KA
Bioorg Med Chem; 2009 Sep; 17(17):6329-39. PubMed ID: 19665385
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of potent and selective inhibitors of Candida albicans N-myristoyltransferase based on the benzothiazole structure.
Yamazaki K; Kaneko Y; Suwa K; Ebara S; Nakazawa K; Yasuno K
Bioorg Med Chem; 2005 Apr; 13(7):2509-22. PubMed ID: 15755653
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors.
Sheng C; Xu H; Wang W; Cao Y; Dong G; Wang S; Che X; Ji H; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2010 Sep; 45(9):3531-40. PubMed ID: 20615585
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14alpha-demethylase (CYP51) of fungi.
Zhu J; Lu J; Zhou Y; Li Y; Cheng J; Zheng C
Bioorg Med Chem Lett; 2006 Oct; 16(20):5285-9. PubMed ID: 16905318
[TBL] [Abstract][Full Text] [Related]
17. Novel antifungal agents which inhibit lanosterol 14alpha-demethylase in Candida albicans CCH442.
Zakula D; Capobianco JO; Goldman RC
J Antimicrob Chemother; 1997 Feb; 39(2):261-4. PubMed ID: 9069550
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, Antifungal Activity and Molecular Docking of Thiochroman-4-one Derivatives.
Zhong Y; Han X; Li S; Qi H; Song Y; Qiao X
Chem Pharm Bull (Tokyo); 2017; 65(10):904-910. PubMed ID: 28966274
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel macrocyclic antifungal peptides.
Mulder MP; Kruijtzer JA; Breukink EJ; Kemmink J; Pieters RJ; Liskamp RM
Bioorg Med Chem; 2011 Nov; 19(21):6505-17. PubMed ID: 21940175
[TBL] [Abstract][Full Text] [Related]
20. Rational design of N-alkyl derivatives of 2-amino-2-deoxy-d-glucitol-6P as antifungal agents.
Melcer A; Łacka I; Gabriel I; Wojciechowski M; Liberek B; Wiśniewski A; Milewski S
Bioorg Med Chem Lett; 2007 Dec; 17(23):6602-6. PubMed ID: 17920268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
